POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...

Please provide your email address to receive an email when new articles are posted on . Subacromial decompression with arthroscopic rotator cuff repair yielded a 21% risk reduction for revision ...

Many countries have strict regulations to ensure new drugs are effective and are worth the money before doctors can prescribe them. But surgical procedures are often less strictly regulated. This can ...

Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site. Posimir ® (bupivacaine solution) is now available for ...

Arthroscopic subacromial decompression surgery does not reduce pain any more than arthroscopy alone in people with shoulder impingement, researchers say. "[T]he findings from our study suggest that ...

Innocoll Pharmaceuticals Limited, a commercial-stage biotechnology company and portfolio business of Gurnet Point Capital, and DURECT Corporation announced the recent commercial launch of Posimir ...

POSIMIR® is now commercially available in the U.S. for the treatment of post-surgical pain in adults following arthroscopic subacromial decompression surgery DURECT recently received an $8 million ...